These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 135920)

  • 1. [Long term therapy over nine years with Spironolacton in hydropic cardiac insufficiency].
    Ehrlich U; Klepzig H
    Med Klin; 1976 Sep; 71(38):1546-54. PubMed ID: 135920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of combined captopril-spironolactone therapy of cardiac insufficiency on kidney function and serum electrolyte values].
    Cserhalmi L
    Orv Hetil; 1998 Jan; 139(2):63-6. PubMed ID: 9451904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long term experiences with a solid spironolactone-furosemide combination in heart insufficiency and hypertension].
    Bachour G
    Med Klin Prax; 1982 May; 77(10):54-8. PubMed ID: 6808328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spironolactone in digitalis-requiring cardiac insufficiency following pacemaker implantation].
    Sabin G; Klüsener W
    Med Klin; 1981 Jan; 76(1):20-3. PubMed ID: 7254119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB; Rao K; Sawyer R; Gottlieb SS
    J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of 2 diuretic-containing combination preparations in patients with edematous heart failure].
    Mauersberger H; Rangoonwala B; Ehrlich E
    Wien Med Wochenschr; 1985 Apr; 135(8):205-13. PubMed ID: 4013351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with the cardiac glycoside Gitoformat (author's transl)].
    Benda L; Zenz W
    Med Klin; 1978 Jul; 73(30):1081-4. PubMed ID: 672762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J; Fraccarollo D
    Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
    Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium supplements in patients receiving long-term diuretics for oedema.
    Lawson DH; Boddy K; Gray JM; Mahaffey M; Mills E
    Q J Med; 1976 Jul; 45(179):469-78. PubMed ID: 948547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of coronary insufficiency with diuretics].
    Donat K
    Fortschr Med; 1981 Apr; 99(16):567-72. PubMed ID: 7227949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
    van den Meiracker AH; Baggen RG; Pauli S; Lindemans A; Vulto AG; Poldermans D; Boomsma F
    J Hypertens; 2006 Nov; 24(11):2285-92. PubMed ID: 17053552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutically induced aldosteronism in hydropic cardiac insufficiency].
    Kaufmann W
    Arzneimittelforschung; 1969 May; 19(5):802-3. PubMed ID: 5819794
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects and therapy of hydropic heart insufficiency. Results of a multicenter field study].
    Angelkort B; Letzel H
    Fortschr Med; 1981 Dec; 99(45):1911-8. PubMed ID: 7030895
    [No Abstract]   [Full Text] [Related]  

  • 20. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.